학술논문
Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome
Document Type
Article
Author
Source
In: Blood . (Blood, 24 December 2020, 136(26):2994-3003)
Subject
Language
English
ISSN
15280020
00064971
00064971